Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets.

Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Abstract Text:

    yi luYi Lu,hang-ping yaoHang-Ping Yao,ming-hai wangMing-Hai Wang,yi luYi Lu,hang-ping yaoHang-Ping Yao,ming-hai wangMing-Hai Wang,yi luYi Lu,hang-ping yaoHang-Ping Yao,ming-hai wangMing-Hai Wang,

    Aberrant expression of the RON (Recepteur d'Origine Nantais) receptor tyrosine kinase, accompanied by generation of multiple splicing or truncated variants, contributes to pathogenesis of epithelial cancers. Currently, six variants including RONDelta170, Delta165, Delta160, Delta155, Delta110, and Delta55 with various deletions or truncations in the extracellular or intracellular regions have been identified. The extracellular sequences contain functional structures such as sema domain, PSI motif, and IPT units. The deletion or truncation results in constitutive phosphorylation and increased kinase activities. Oncogenic RONDelta160, generated by exclusion of the first IPT unit, is a typical example. In contrast, the deletion adjacent to the conserved MET(1254) in the kinase domain converts RON into a dominant negative agent. Among three mechanisms underlying isoform production, the switch from constitutive to alternative pre-mRNA splicing is the major event in producing RON variants in cancer cells. Most of the RON variants have the ability to activate multiple signaling cascades with a different substrate specificity and phosphorylation profile. They regulate cell migration, invasion, and proliferation, which contribute to the invasive phenotype and promote the malignant progression. Thus, determining the pathogenesis of RON variants is critical in understanding the mechanisms underlying cancer initiation and progression. Targeting oncogenic signals elicited by RON or its variants by special antibody or small interfering RNA could provide a novel strategy for the treatment of malignant epithelial cancers.

    Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Publishing Authors By Initials

    y luY Lu,hp yaoHP Yao,mh wangMH Wang,y luY Lu,hp yaoHP Yao,mh wangMH Wang,y luY Lu,hp yaoHP Yao,mh wangMH Wang,

    For similar biological phenomena, cell phenomena, and immunity: cell physiology: cell communication: signal transduction research abstracts see: biological phenomena, cell phenomena, and immunity: cell physiology: cell communication: signal transduction research

    PUBMED ID PMID:

    MEDLINE DATE:

    Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Cancer letters

    VOLUME: 257

    Page Numbers: 157-64

    Journal Abbreviation: Cancer Lett.

    ISSN: 0304-3835

    DAY: 21

    MONTH: 09

    YEAR: 2007

    Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Information

    Number of References: 52

    LANGUAGE: eng

    NlmUniqueID: 7600053

    Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Keywords Mesh Terms:

    KEYWORDS: Signal Transduction

    MESH TERMS: drug effects

    Chemical & Substance for Abstract: Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Information

    Substance Name: Receptor Protein-Tyrosine Kinases

    Registry Number: EC 2.7.1.112

    Grant and Affiliation Information for Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets.

    AFFILIATION: Laboratory of Cancer Biology and Therapeutics, Institute of Infectious Diseases at First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, People's Republic of China.

    Country: Ireland

    Ireland Research PublicationIreland Research Publication

    AGENCY: United States NCI

    GRANT: R01 CA91980

    ACRONYM: CA

    MEDLINETA: Cancer Lett

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News